{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:13:16Z","timestamp":1763766796972,"version":"3.45.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:p>Endometrial cancer (EC) is a major reproductive system tumor and a common cancer in women. Polycystic ovary syndrome (PCOS) is one of the most prevalent female reproductive endocrine disorders. The incidence of EC is significantly higher in individuals with PCOS. This study seeks to elucidate the organic correlations and interaction mechanisms between the 2 diseases through series of exploration of key genes with a bioinformatics analysis. The PCOS sample data and the EC single-cell dataset were downloaded from the gene expression omnibus database. The EC sample data were retrieved from the cancer genome atlas public database. The random survival forest method was employed to identify key genes associated with the prognosis of PCOS and EC comorbidity. Corresponding analyses on functional pathway enrichment, regulatory networks, and immune micro-environment are conducted. From a bioinformatics perspective, the association and interaction mechanisms between PCOS and EC comorbidity were explored to provide research and development references for the prevention and control of PCOS and EC comorbidity. Five key genes associated with the prognosis of PCOS and EC comorbidity were identified using the random survival forest method. The identified genes are SYTL1, PARVG, ID4, IL1RN, and S100A9. The abnormal expression of these key genes has impacted various enrichment pathways, including the TGF-\u03b2 signaling-pathway, motif regulatory networks (such as motif cisbp__M4556), and miRNA regulatory networks, which encompass genes such as ATM, BARD1 and BRCA1. Furthermore, these also influence the immune cell microenvironment, such as T cells regulatory. Collectively, these key genes play a significant role in the occurrence and progression of comorbidities through the pathways mentioned above. The dysregulation of key genes (SYTL1, PARVG, ID4, IL1RN, S100A9) in the context of PCOS-EC comorbidities, along with their associated enrichment pathways, including the TGF-\u03b2 signaling-pathway and immune microenvironment, plays a significant role in the occurrence and progression of EC.<\/jats:p>","DOI":"10.1097\/md.0000000000045831","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:02:38Z","timestamp":1763154158000},"page":"e45831","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Key genes and associated mechanisms of PCOS and EC comorbidity: A bioinformatics analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-7057","authenticated-orcid":false,"given":"Yingsha","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Gynecology, Ningbo No.2 Hospital, Ningbo, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Women\u2019s Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China"},{"name":"Department of Obstetrics, Hangzhou Linping District Maternal and Child Health Care Hospital, Hangzhou, Zhejiang Province, China"},{"name":"Key Laboratory of Women\u2019s Reproductive Health of Zhejiang Province, Women\u2019s Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-7108","authenticated-orcid":false,"given":"Xiaoming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Women\u2019s Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China"},{"name":"Key Laboratory of Women\u2019s Reproductive Health of Zhejiang Province, Women\u2019s Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251121","first-page":"305","article-title":"Bioinformatics. Introduction.","volume":"85","author":"Rothberg","year":"2012","journal-title":"Yale J Biol Med"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bib\/bbad016","article-title":"Network models in bioinformatics: modeling and analysis for complex diseases.","volume":"24","author":"Milano","year":"2023","journal-title":"Brief Bioinform"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives.","volume":"12","author":"Khan","year":"2019","journal-title":"Appl Clin Genet"},{"key":"R4-20251121","doi-asserted-by":"crossref","first-page":"112031","DOI":"10.1016\/j.biopha.2021.112031","article-title":"Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics.","volume":"142","author":"Pei","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1080\/09513590.2016.1203409","article-title":"The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations.","volume":"32","author":"Li","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s43032-021-00515-4","article-title":"The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art.","volume":"29","author":"Bruni","year":"2022","journal-title":"Reprod Sci"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43032-022-00863-9","article-title":"Multiomics analysis-based biomarkers in diagnosis of polycystic ovary syndrome.","volume":"30","author":"Rani","year":"2023","journal-title":"Reprod Sci"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/AOG.0000000000004989","article-title":"Endometrial hyperplasia.","volume":"140","author":"Ring","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R9-20251121","article-title":"Endometrial Hyperplasia.","author":"Singh","year":"2023","journal-title":"StatPearls"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00404-021-06380-5","article-title":"Endometrial hyperplasia as a risk factor of endometrial cancer.","volume":"306","author":"Nees","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"R11-20251121","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer. Review.","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/0284186X.2018.1540886","article-title":"The role of biomarkers in endometrial cancer and hyperplasia: a literature review.","volume":"58","author":"Hutt","year":"2019","journal-title":"Acta Oncol"},{"key":"R13-20251121","doi-asserted-by":"crossref","first-page":"18057","DOI":"10.1038\/s41598-023-44269-2","article-title":"RNA modification regulator DDC in endometrial cancer affects the tumor microenvironment and patient prognosis.","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci Rep"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1055-9965.EPI-18-1031","article-title":"Genome-wide association studies of endometrial cancer: latest developments and future directions.","volume":"28","author":"O\u2019Mara","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"852746","DOI":"10.3389\/fonc.2022.852746","article-title":"Machine learning for endometrial cancer prediction and prognostication.","volume":"12","author":"Bhardwaj","year":"2022","journal-title":"Front Oncol"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3390\/cells11132119","article-title":"Tissue-based proteomic profiling in patients with hyperplasia and endometrial cancer.","volume":"11","author":"Akkour","year":"2022","journal-title":"Cells"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamaoncol.2018.5188","article-title":"Association between polycystic ovary syndrome and cancer risk. Letter.","volume":"5","author":"Yin","year":"2019","journal-title":"JAMA Oncol"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/09513590.2020.1730794","article-title":"The polycystic ovary syndrome and gynecological cancer risk. Review.","volume":"36","author":"Meczekalski","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/00369330221107099","article-title":"Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: an updated meta-analysis. Article.","volume":"67","author":"Li","year":"2022","journal-title":"Scott Med J"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovary syndrome and endometrial cancer. Article.","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin Reprod Med"},{"key":"R21-20251121","first-page":"1082","article-title":"Polycystic ovary syndrome and endometrial carcinoma (vol 361, pg 1810, 2003). Correction.","volume":"362","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"R22-20251121","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.7314\/APJCP.2014.15.17.7011","article-title":"Polycystic ovary syndrome and risk of endometrial cancer: a mini-review.","volume":"15","author":"Tokmak","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Review.","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4939-3578-9_6","article-title":"A practical guide to the cancer genome atlas (TCGA).","volume":"1418","author":"Wang","year":"2016","journal-title":"Methods Mol Biol"},{"key":"R25-20251121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database.","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol Biol"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R27-20251121","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/JTO.0b013e318233d835","article-title":"Random survival forests.","volume":"6","author":"Taylor","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R28-20251121","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-20251121","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R30-20251121","doi-asserted-by":"crossref","first-page":"1030198","DOI":"10.3389\/fimmu.2023.1030198","article-title":"Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"R31-20251121","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods.","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J Cell Physiol"},{"key":"R32-20251121","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R33-20251121","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT.","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R34-20251121","doi-asserted-by":"crossref","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","article-title":"Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.","volume":"97","author":"Kaur","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-20251121","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","article-title":"Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment.","volume":"54","author":"Barkley","year":"2022","journal-title":"Nat Genet"},{"key":"R36-20251121","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13048-023-01097-2","article-title":"Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments.","volume":"16","author":"Meijuan","year":"2023","journal-title":"J Ovarian Res"},{"key":"R37-20251121","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12935-021-02038-z","article-title":"Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R38-20251121","doi-asserted-by":"crossref","first-page":"e13250","DOI":"10.1111\/sji.13250","article-title":"Identification of tumour antigens and immune subtypes in the development of an anti-cancer vaccine for endometrial carcinoma.","volume":"97","author":"Feng","year":"2023","journal-title":"Scand J Immunol"},{"key":"R39-20251121","doi-asserted-by":"crossref","first-page":"e58257","DOI":"10.1371\/journal.pone.0058257","article-title":"Genome-wide association study link novel loci to endometriosis.","volume":"8","author":"Albertsen","year":"2013","journal-title":"PLoS One"},{"key":"R40-20251121","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12958-019-0476-9","article-title":"Epigenetic role of the nuclear factor NF-Y on ID gene family in endometrial tissues of women with endometriosis: a case control study.","volume":"17","author":"Amirteimouri","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"R41-20251121","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1995-7645(13)60030-9","article-title":"Correlation between IL-1\u03b2, IL-1Ra gene polymorphism and occurrence of polycystic ovary syndrome infertility.","volume":"6","author":"Xia","year":"2013","journal-title":"Asian Pac J Trop Med"},{"key":"R42-20251121","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2009.09.042","article-title":"Genotype and haplotype determination of interleukin (IL) 1 beta (g. -511C>T and g. +3954C>T) and IL-1RN in polycystic ovary syndrome.","volume":"94","author":"Yang","year":"2010","journal-title":"Fertil Steril"},{"key":"R43-20251121","doi-asserted-by":"crossref","first-page":"888194","DOI":"10.3389\/fmolb.2022.888194","article-title":"Key genes associated with non-alcoholic fatty liver disease and polycystic ovary syndrome.","volume":"9","author":"Chen","year":"2022","journal-title":"Front Mol Biosci"},{"key":"R44-20251121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0090-8258(91)90338-6","article-title":"Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancer.","volume":"42","author":"Van Le","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R45-20251121","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.rbmo.2020.05.008","article-title":"Endometrial stromal cell inflammatory phenotype during severe ovarian endometriosis as a cause of endometriosis-associated infertility.","volume":"41","author":"Anupa","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"R46-20251121","doi-asserted-by":"crossref","first-page":"104995","DOI":"10.1016\/j.jprot.2023.104995","article-title":"DIA-based analysis of the menstrual blood proteome identifies association between CXCL5 and IL1RN and endometriosis.","volume":"289","author":"Ji","year":"2023","journal-title":"J Proteomics"},{"key":"R47-20251121","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00404-022-06686-y","article-title":"Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in varies polycystic ovary syndrome.","volume":"306","author":"Qu","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"R48-20251121","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fbioe.2020.00328","article-title":"Protein network studies on PCOS biomarkers with S100A8, druggability assessment, and RNA aptamer designing to control its cyst migration effect.","volume":"8","author":"Manibalan","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"R49-20251121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/jcmm.14642","article-title":"S100-A9 protein in exosomes derived from follicular fluid promotes inflammation via activation of NF-\u03baB pathway in polycystic ovary syndrome.","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R50-20251121","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.3802\/jgo.2021.32.e30","article-title":"Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer.","volume":"32","author":"Cheng","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"R51-20251121","doi-asserted-by":"crossref","first-page":"110589","DOI":"10.1016\/j.mce.2019.110589","article-title":"MALAT1 is involved in the pathophysiological process of PCOS by modulating TGF\u03b2 signaling in granulosa cells.","volume":"499","author":"Zhang","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"R52-20251121","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719113485294","article-title":"The role of TGF-\u03b2 in polycystic ovary syndrome.","volume":"21","author":"Raja-Khan","year":"2014","journal-title":"Reprod Sci"},{"key":"R53-20251121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13048-017-0375-7","article-title":"DHEA-induced ovarian hyperfibrosis is mediated by TGF-\u03b2 signaling pathway.","volume":"11","author":"Wang","year":"2018","journal-title":"J Ovarian Res"},{"key":"R54-20251121","doi-asserted-by":"crossref","first-page":"113219","DOI":"10.1016\/j.biopha.2022.113219","article-title":"Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in endometrial cancer via targeting TGF-beta1\/SMAD4 signaling pathway.","volume":"152","author":"Chen","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R55-20251121","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/15384101.2020.1777804","article-title":"miR-96-5p regulated TGF-\u03b2\/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1.","volume":"19","author":"Chen","year":"2020","journal-title":"Cell Cycle"},{"key":"R56-20251121","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3892\/ijo.2015.2920","article-title":"Transcriptome analysis reveals that Mullerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis. Article.","volume":"46","author":"Chung","year":"2015","journal-title":"Int J Oncol"},{"key":"R57-20251121","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.7150\/jca.60700","article-title":"Functional profiles of mullerian inhibiting substance\/anti-mullerian hormone (MIS\/AMH) in primarily cultured endometrial cancer cells.","volume":"12","author":"Kim","year":"2021","journal-title":"J Cancer"},{"key":"R58-20251121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1073\/pnas.0407772101","article-title":"Endometrial cancer is a receptor-mediated target for mullerian inhibiting substance. article.","volume":"102","author":"Renaud","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R59-20251121","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/labinvest.2009.52","article-title":"S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.","volume":"89","author":"Xie","year":"2009","journal-title":"Lab Invest"},{"key":"R60-20251121","doi-asserted-by":"crossref","first-page":"975201","DOI":"10.3389\/fonc.2022.975201","article-title":"Importance of the endometrial immune environment in endometrial cancer and associated therapies.","volume":"12","author":"van der Woude","year":"2022","journal-title":"Front Oncol"},{"key":"R61-20251121","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/path.6012","article-title":"The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.","volume":"258","author":"L\u00f3pez-Janeiro","year":"2022","journal-title":"J Pathol"},{"key":"R62-20251121","doi-asserted-by":"crossref","first-page":"919637","DOI":"10.3389\/fcell.2022.919637","article-title":"Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer.","volume":"10","author":"He","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R63-20251121","doi-asserted-by":"crossref","first-page":"e005443","DOI":"10.1136\/jitc-2022-005443","article-title":"Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.","volume":"10","author":"Palomero","year":"2022","journal-title":"J ImmunoTher Cancer"},{"key":"R64-20251121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","article-title":"Assessing Tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno-oncology biomarkers working group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors.","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"R65-20251121","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1158\/2326-6066.CIR-20-0149","article-title":"Prognostic integrated image-based immune and molecular profiling in early-stage endometrial cancer.","volume":"8","author":"Horeweg","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"R66-20251121","doi-asserted-by":"crossref","first-page":"551","DOI":"10.21037\/atm-20-6049","article-title":"Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancer.","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"R67-20251121","doi-asserted-by":"crossref","first-page":"937309","DOI":"10.3389\/fgene.2022.937309","article-title":"Bioinformatics searching of diagnostic markers and immune infiltration in polycystic ovary syndrome.","volume":"13","author":"Yao","year":"2022","journal-title":"Front Genet"},{"key":"R68-20251121","doi-asserted-by":"crossref","first-page":"1192313","DOI":"10.3389\/fmolb.2023.1192313","article-title":"Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods.","volume":"10","author":"Wu","year":"2023","journal-title":"Front Mol Biosci"},{"key":"R69-20251121","doi-asserted-by":"crossref","first-page":"e20210042","DOI":"10.1084\/jem.20210042","article-title":"Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function.","volume":"219","author":"Dyck","year":"2022","journal-title":"J Exp Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:03:39Z","timestamp":1763766219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":69,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045831","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2024-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}